These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 27693004

  • 1. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S, Pollack S, Roth M, Reichek N, Guerci A, Cao JJ.
    Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
    [Abstract] [Full Text] [Related]

  • 2. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 3. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
    Mulders TA, Sivapalaratnam S, Stroes ES, Kastelein JJ, Guerci AD, Pinto-Sietsma SJ.
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
    [Abstract] [Full Text] [Related]

  • 4. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.
    J Am Heart Assoc; 2018 Jun 13; 7(12):. PubMed ID: 29899017
    [Abstract] [Full Text] [Related]

  • 5. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ, Park SE, Oh HG, Park CY, Oh KW, Park SW, Blankstein R, Plutzky J, Lee WY.
    Atherosclerosis; 2015 May 13; 240(1):242-9. PubMed ID: 25818250
    [Abstract] [Full Text] [Related]

  • 6. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.
    Mortensen MB, Falk E, Li D, Nasir K, Blaha MJ, Sandfort V, Rodriguez CJ, Ouyang P, Budoff M.
    JACC Cardiovasc Imaging; 2018 Feb 13; 11(2 Pt 1):221-230. PubMed ID: 28624395
    [Abstract] [Full Text] [Related]

  • 7. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL.
    JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
    Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E.
    J Am Coll Cardiol; 2016 Aug 30; 68(9):881-91. PubMed ID: 27561760
    [Abstract] [Full Text] [Related]

  • 11. Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins.
    Osawa K, Trejo MEP, Nakanishi R, McClelland RL, Blaha MJ, Blankstein R, McEvoy JW, Ceponiene I, Stein JH, Sacco RL, Polak JF, Budoff MJ.
    Eur J Prev Cardiol; 2018 Dec 30; 25(18):1980-1987. PubMed ID: 30183342
    [Abstract] [Full Text] [Related]

  • 12. Progression of CAC Score and Risk of Incident CVD.
    Radford NB, DeFina LF, Barlow CE, Lakoski SG, Leonard D, Paixao AR, Khera A, Levine BD.
    JACC Cardiovasc Imaging; 2016 Dec 30; 9(12):1420-1429. PubMed ID: 27372023
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study.
    Kaasenbrood L, Poulter NR, Sever PS, Colhoun HM, Livingstone SJ, Boekholdt SM, Pressel SL, Davis BR, van der Graaf Y, Visseren FL, CARDS, ALLHAT, and ASCOT Investigators.
    Circ Cardiovasc Qual Outcomes; 2016 May 30; 9(3):213-21. PubMed ID: 27174798
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Routine CAC-scoring prior to initiation of statin therapy - a European perspective.
    Mahabadi AA, Nasir K, Rassaf T.
    Eur J Prev Cardiol; 2019 Sep 30; 26(14):1559-1561. PubMed ID: 30913900
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.